Statin treatment is highly cost effective in young adult men with LDL cholesterol ≥130 mg/dL Clinical study 27 November 2021 Pages: 23 - 23
Similar costs for mCRPC patients treated with abiraterone vs enzalutamide in Scotland Unknown 27 November 2021 Pages: 22 - 22
Rotavac and Rotasiil likely cost effective for a rotavirus vaccination programme in the Philippines Clinical study 27 November 2021 Pages: 21 - 21
Ranibizumab, aflibercept not cost effective for polypoidal choroidal vasculopathy in Thailand Clinical study 27 November 2021 Pages: 20 - 20
Providing free contraception to prevent Zika-related birth defects cost saving in Puerto Rico Clinical study 27 November 2021 Pages: 19 - 19
PROSPER exercise programme cost effective after breast surgery Clinical study 27 November 2021 Pages: 18 - 18
Originator-to-biosimilar non-medical switch may not yield such great cost savings Clinical study 27 November 2021 Pages: 17 - 17
More invasive prophylactic strategies worth it for BRCA1/2 mutation-positive women Clinical study 27 November 2021 Pages: 16 - 16
Invasive meningococcal disease uncommon but a high economic burden for Spain Clinical study 27 November 2021 Pages: 15 - 15
Discontinuing antidepressants: no QALY gain, no cost savings in the short term in the UK Clinical study 27 November 2021 Pages: 14 - 14
Counting the cost of rotavirus hospitalisation among young children in Bangladesh Clinical study 27 November 2021 Pages: 13 - 13
Costs for diagnostic evaluation of abnormal uterine bleeding are high, vary greatly in the USA Clinical study 27 November 2021 Pages: 12 - 12
Cost of treating breast cancer substantial and increasing in New Zealand Clinical study 27 November 2021 Pages: 11 - 11
Community distribution of naloxone appears to be cost effective to prevent opioid overdose Clinical study 27 November 2021 Pages: 10 - 10
CDX2 testing + FOLFOX for CDX2-negative colon cancer patients cost-effective strategy Clinical study 27 November 2021 Pages: 9 - 9
Catch-up 9-valent HPV vaccine cost-effective in girls in Hong Kong Clinical study 27 November 2021 Pages: 8 - 8
Catastrophic out-of-pocket costs for around 10% of Medicare FFS patients with HF in the USA Clinical study 27 November 2021 Pages: 7 - 7
Burden of spinal muscular atrophy high, varies according to disease type and motor function Clinical study 27 November 2021 Pages: 6 - 6
Breast reduction surgery for symptomatic breast hypertrophy cost effective in Australia Clinical study 27 November 2021 Pages: 5 - 5
BioFire FilmArray Blood Culture system cost saving for identifying E.coli bloodstream infections Clinical study 27 November 2021 Pages: 4 - 4
Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA Clinical study 27 November 2021 Pages: 3 - 3
Bariatric surgery-related costs in Australia now largely driven by operating theatre costs Clinical study 27 November 2021 Pages: 2 - 2
Advanced hybrid closed-loop Mini-Med 780G system cost effective for T1DM in Sweden Clinical study 27 November 2021 Pages: 1 - 1
UK's NICE does not recommend tucatinib for HER2-positive metastatic breast cancer News item 13 November 2021 Pages: 37 - 37
Scottish Medicines Consortium accepts three new medicines and rejects one News item 13 November 2021 Pages: 36 - 36
NZ's Pharmac to fund baricitinib for moderate-to-severe COVID-19 News item 13 November 2021 Pages: 35 - 35
NZ's Pharmac negotiates deal for Roche's monoclonal antibodies for COVID-19 News item 13 November 2021 Pages: 34 - 34
NICE draft guidance recommends dapagliflozin for some patients with chronic kidney disease Unknown 13 November 2021 Pages: 33 - 33
New NICE guideline for diagnosis and management of myalgic encephalopathy/chronic fatigue syndrome Media release 13 November 2021 Pages: 32 - 32
ICER revised report: tezepelumab reduces asthma exacerbations but questions remain News item 13 November 2021 Pages: 31 - 31
Vedolizumab cost effective versus adalimumab for ulcerative colitis Clinical study 13 November 2021 Pages: 30 - 30
Universal HCV testing of pregnant women would be cost effective in Ireland Clinical study 13 November 2021 Pages: 29 - 29
Unilateral cochlear implants cost effective in adults in UK Clinical study 13 November 2021 Pages: 28 - 28
Tumour molecular classification-guided treatment cost effective for stage I or II high-risk EC Clinical study 13 November 2021 Pages: 27 - 27
Suboptimal lipid-lowering therapy in secondary prevention of atherosclerotic CVD incurs high cost in Italy Clinical study 13 November 2021 Pages: 26 - 26
STEP-KOA knee osteoarthritis programme is cost effective in VA population in the USA Clinical study 13 November 2021 Pages: 25 - 25
Rivaroxaban reduces HRU, costs vs warfarin for AF in US patients with obesity and diabetes Clinical study 13 November 2021 Pages: 24 - 24
Remote pulse-ox monitoring for COVID-19 patients saves costs, improves outcomes in the USA Clinical study 13 November 2021 Pages: 23 - 23
Prescription digital therapeutic, reSET-O, saves costs in US patients with opioid use disorder Clinical study 13 November 2021 Pages: 22 - 22
PCSK9 inhibitors not cost effective versus other antihyperlipidaemics Clinical study 13 November 2021 Pages: 21 - 21
Oral semaglutide a cost-effective option for patients with uncontrolled T2DM Clinical study 13 November 2021 Pages: 20 - 20
No benefit of peritoneal dialysis over haemodialysis for uninsured ESKD patients in the USA Clinical study 13 November 2021 Pages: 19 - 19
MRI-guided IV alteplase therapy worth it for stroke with unknown time of onset in Germany Clinical study 13 November 2021 Pages: 18 - 18
Lower back pain a substantial economic burden in Switzerland Clinical study 13 November 2021 Pages: 16 - 16
Insulin glargine/lixisenatide good value in type 2 diabetes Clinical study 13 November 2021 Pages: 15 - 15
High-flow nasal cannula use cost effective in infants hospitalised with bronchiolitis in Colombia Unknown 13 November 2021 Pages: 14 - 14
Government spending on childhood immunisation increases Clinical study 13 November 2021 Pages: 13 - 13
FreeStyle Libre Flash cost effective for glucose monitoring Clinical study 13 November 2021 Pages: 12 - 12
Empagliflozin less costly than other branded AHAs for T2DM patients with CVD in the USA Clinical study 13 November 2021 Pages: 11 - 11